VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CAHCardinal Health, Inc.
$237.92$56.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksCAHBalance Sheet

Cardinal Health, Inc. (CAH) Balance Sheet

30Y historyFree accessUpdated daily

The company maintains a precarious capital structure with a negative equity position of $2.8 billion and a rising debt load that has increased from $4.7 billion in 2024Q2 to $8.9 billion in 2026Q3.

CAH Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMJun'25Jun'24Jun'23Jun'22Jun'21Jun'20Jun'19Jun'18Jun'17Jun'16Jun'15Jun'14Jun'13Jun'12Jun'11Jun'10Jun'09Jun'08Jun'07Jun'06Jun'05Jun'04Jun'03Jun'02Jun'01Jun'00Jun'99Jun'98Jun'97Jun'96
Total Current Assets38.06B36.37B34.88B33.74B32.94B31.05B25.94B25.75B24.55B28.34B21.96B21.75B17.94B17.77B17.51B16.32B14.92B20.98B14.28B14.54B16.58B13.53B13.06B13.25B11.91B10.72B8.45B5.2B4.79B2.49B2.34B
Cash & Short-Term Investments3.94B3.87B5.13B4.08B4.72B3.41B2.77B2.53B1.76B6.88B2.36B4.62B2.87B1.9B2.27B1.93B2.76B1.22B1.68B1.44B1.69B1.5B1.1B1.72B1.38B934.1M539.5M185.4M373.3M243.1M304.3M
Cash Only3.94B3.87B5.13B4.08B4.72B3.41B2.77B2.53B1.76B6.88B2.36B4.62B2.87B1.9B2.27B1.93B2.76B1.22B1.29B1.31B1.19B1.4B1.1B1.72B1.38B934.1M539.5M185.4M373.3M243.1M304.3M
Short-Term Investments000000000000000000383.7M132M498.4M99.8M000000000
Accounts Receivable13.65B13.24B12.08B11.11B10.56B9.1B8.26B8.45B7.8B8.05B7.41B6.52B5.38B6.3B6.36B6.16B5.17B5.21B4.99B4.71B3.81B3.1B3.43B2.78B2.3B2.41B2.4B1.6B1.44B672.2M612.3M
Days Sales Outstanding19.7821.7219.4519.7821.2620.4519.7221.1920.8122.622.2423.2221.5622.7621.5721.8919.1619.8320.8319.8117.4515.5819.4217.9116.3818.3422.8323.2924.8713.3424.17
Inventory18.01B16.83B14.96B16.12B15.64B14.59B13.2B12.82B12.31B11.3B10.62B9.21B8.27B8.37B7.86B7.33B6.36B6.83B6.77B7.38B7.49B7.25B7.47B7.62B7.36B6.29B4.66B2.94B2.61B1.44B1.27B
Days Inventory Outstanding27.4228.6524.8829.732.6434.2132.9833.7434.6633.4233.6934.7235.1131.7827.8627.1824.4927.0429.5433.0236.5438.7945.5453.2557.0651.7548.2248.2351.1932.4355.08
Other Current Assets2.47B2.43B2.71B72M01.1B00756M000000007.19B264.2M354.8M3.03B1.05B262.5M341.9M218.3M236.3M851.1M473.1M368.4M135.6M155.1M
Total Non-Current Assets18.63B16.75B10.24B9.61B10.94B13.4B14.83B15.22B15.4B11.77B12.17B8.39B8.09B8.05B6.75B6.53B5.07B4.14B9.17B8.61B6.86B8.31B8.31B5.27B4.53B3.93B3.58B3.2B2.69B604.7M480.9M
Property, Plant & Equipment2.93B2.86B2.53B2.46B2.36B2.36B2.37B2.36B2.49B1.88B1.8B1.51B1.46B1.49B1.55B1.51B1.47B1.46B1.74B1.65B1.5B2.48B2.36B2.09B1.89B1.84B1.73B1.56B1.47B277.5M166.9M
Fixed Asset Turnover87.19x77.88x89.69x83.29x76.80x68.84x64.63x61.77x55.01x69.17x67.68x68.08x62.43x67.89x69.34x67.88x67.06x65.55x50.32x52.73x52.93x29.25x27.29x27.15x26.99x26.08x22.19x16.08x14.36x66.28x55.40x
Goodwill13.7B9.69B4.72B4.61B5.86B7.99B8.36B8.38B8.32B7.22B7.17B5.07B4.88B4.6B3.98B3.85B2.25B2.27B6.16B5.86B4.28B4.84B0001.18B00000
Intangible Assets02.49B1.73B1.47B1.77B2.1B2.92B3.43B3.91B1.99B2.26B948M992M973M414M413M0000004.94B2.33B1.54B01.04B942.1M850.5M122.1M114.9M
Long-Term Investments14M14M43M56M77M68M0000000000691.5M0916.8M000000000000
Other Non-Current Assets2B1.7B1.22B1.01B876M883M1.19B1.05B682M681M944M866M765M986M807M759M657.8M405.7M384.1M1.1B1.07B1.02B1.01B846.1M1.09B912.4M805.7M700.3M373.7M205.1M199.1M
Total Assets56.69B53.12B45.12B43.35B43.88B44.45B40.77B40.96B39.95B40.11B34.12B30.14B26.03B25.82B24.26B22.85B19.99B25.12B23.45B23.15B23.37B22.06B21.37B18.52B16.44B14.64B12.02B8.4B7.48B3.09B2.83B
Asset Turnover4.49x4.19x5.03x4.73x4.13x3.65x3.75x3.55x3.42x3.24x3.56x3.40x3.50x3.92x4.43x4.49x4.93x3.82x3.73x3.75x3.41x3.29x3.02x3.06x3.11x3.27x3.19x2.99x2.82x5.95x3.27x
Asset Growth %83.24%17.73%4.09%-1.21%-1.29%9.04%-0.48%2.53%-0.4%17.55%13.2%15.78%0.83%6.43%6.19%14.29%-20.42%7.12%1.27%-0.94%5.96%3.23%15.38%12.67%12.26%21.78%43.07%12.39%141.87%9.44%53.39%
Total Current Liabilities41.99B38.9B35.64B33.74B30.55B27.62B23.61B24.11B22.89B21.22B19.7B17.24B15.12B14.59B14.17B13.37B11.54B12.28B10.39B11.46B11.58B9.9B9.37B7.31B6.81B6.57B5.55B2.97B2.73B1.39B1.42B
Accounts Payable37.83B34.71B31.76B29.93B27.13B23.7B21.37B21.54B19.68B17.91B17.31B14.37B12.15B12.29B11.73B11.33B9.49B9.04B8.3B9.16B8.91B7.35B6.43B5.29B5.5B5.32B3.9B2.36B2.14B1.14B1.14B
Days Payables Outstanding56.1259.0952.8355.1556.6355.5653.4256.6755.4152.9554.9354.1751.6146.6641.554236.5935.7836.2440.9843.4439.3439.2136.9542.6743.840.3338.7842.0625.6549.27
Short-Term Debt671M714M551M892M682M976M10M452M1B1.33B587M281M801M168M476M326.7M233.2M367.3M159M16M199M307.9M860.6M228.7M18.2M14.2M423.4M40.2M32M28.3M106M
Deferred Revenue (Current)0000000000000000000000000000000
Other Current Liabilities3.48B-164M042M096M00213M000000001.37B50M34.2M534.2M345.5M55.1M64.3M000561.2M550.7M225.1M175.5M
Current Ratio0.91x0.94x0.98x1.00x1.08x1.12x1.10x1.07x1.07x1.34x1.11x1.26x1.19x1.22x1.24x1.22x1.29x1.71x1.37x1.27x1.43x1.37x1.39x1.81x1.75x1.63x1.52x1.75x1.76x1.79x1.65x
Quick Ratio0.48x0.50x0.56x0.52x0.57x0.60x0.54x0.54x0.53x0.80x0.58x0.73x0.64x0.64x0.68x0.67x0.74x1.15x0.72x0.62x0.78x0.63x0.60x0.77x0.67x0.67x0.68x0.76x0.80x0.76x0.75x
Cash Conversion Cycle-8.91-8.73-8.51-5.67-2.73-0.9-0.71-1.740.063.0713.785.067.887.887.087.0611.0914.1311.8610.5515.0425.7534.2230.7726.2930.7232.7434.0120.1229.98
Total Non-Current Liabilities17.53B16.86B12.69B12.57B14.03B15.04B15.36B10.52B11B12.06B7.85B6.64B4.52B5.25B3.84B3.63B3.18B4.12B5.31B4.32B3.36B3.34B4.02B3.48B3.23B2.63B2.08B1.87B1.8B367.7M369.5M
Long-Term Debt8.24B7.82B4.58B3.85B4.69B5.32B6.76B7.58B8.01B9.07B4.95B5.21B3.17B3.69B2.42B2.17B1.9B3.28B3.69B3.46B2.59B2.32B2.83B2.47B2.21B1.87B1.52B1.22B1.33B277.8M265.1M
Capital Lease Obligations811M811M475M434M437M419M0000000000000000000000000
Deferred Tax Liabilities28.41B2.43B3.09B3.14B3.02B8.31B8.59B2.94B2.98B2.88B2.78B1.43B1.35B1.57B1.42B1.45B1.28B847.3M1.63B859.9M771.9M1.02B1.19B1.01B1.03B759.5M552.5M645.7M467.7M89.8M104.3M
Other Non-Current Liabilities160M5.8B4.54B5.14B5.89B981M0012M118M117M000000-8.4M00000000000100K100K
Total Liabilities59.36B55.76B48.33B46.31B44.58B42.66B38.97B34.63B33.89B33.28B27.55B23.89B19.63B19.84B18.02B17B14.71B16.39B15.7B15.78B14.94B13.25B13.39B10.79B10.04B9.21B7.62B4.83B4.52B1.76B1.79B
Total Debt8.92B9.35B5.61B5.18B5.8B6.71B6.78B8.03B9.01B10.39B5.54B5.49B3.97B3.85B2.89B2.5B2.13B3.65B3.85B3.47B2.79B2.63B3.7B2.7B2.23B1.89B1.95B1.26B1.36B306.1M371.1M
Net Debt4.98B5.47B476M1.1B1.09B3.31B4B5.5B7.25B3.52B3.18B876M1.11B1.95B620M572.7M-626M2.42B2.56B2.16B1.6B1.23B2.6B976.6M843.2M951.1M1.41B1.08B988.7M63M66.8M
Debt / Equity-3.34x----3.74x3.78x1.27x1.49x1.52x0.84x0.88x0.62x0.65x0.46x0.43x0.40x0.42x0.50x0.47x0.33x0.31x0.46x0.35x0.35x0.35x0.44x0.35x0.46x0.23x0.36x
Debt / EBITDA2.82x3.05x2.87x3.58x68.29x5.35x-2.62x7.78x3.66x1.79x2.10x1.69x2.77x1.37x1.37x1.36x2.41x2.39x2.05x1.30x1.26x1.41x1.10x1.07x1.07x1.27x0.99x1.27x0.33x1.11x
Net Debt / EBITDA1.57x1.78x0.24x0.76x12.80x2.64x-1.80x6.26x1.24x1.03x0.34x0.47x1.40x0.29x0.31x-0.40x1.60x1.58x1.28x0.75x0.59x0.99x0.40x0.41x0.54x0.92x0.84x0.92x0.07x0.20x
Interest Coverage6.38x10.77x24.55x8.89x-4.33x2.79x-14.85x6.96x0.31x10.57x13.79x14.95x14.52x8.22x18.87x17.32x11.73x6.47x10.55x------------
Total Equity-2.67B-2.63B-3.21B-2.96B-706M1.79B1.79B6.33B6.06B6.83B6.57B6.26B6.4B5.97B6.24B5.85B5.28B8.72B7.75B7.38B8.49B8.59B7.98B7.67B6.39B5.44B4.4B3.57B2.95B1.33B1.04B
Equity Growth %1.42%18%-8.62%-318.84%-139.35%0.11%-71.69%4.47%-11.26%3.91%5.04%-2.27%7.13%-4.31%6.75%10.86%-39.53%12.61%5.02%-13.12%-1.19%7.73%3.93%20.05%17.58%23.56%23.27%20.8%121.39%28.86%88.95%
Book Value per Share-11.32-10.88-13.00-11.29-2.536.106.1221.0319.2321.3419.9118.6718.5517.3717.8916.5914.6024.1321.2818.2319.8119.7118.5516.9114.1011.739.698.347.095.604.49
Total Shareholders' Equity-2.83B-2.78B-3.21B-2.96B-709M1.79B1.79B6.33B6.06B6.81B6.55B6.26B6.4B5.97B6.24B5.85B5.28B8.72B7.75B7.38B8.49B8.59B7.98B7.67B6.39B5.44B4.4B3.57B2.95B1.33B1.04B
Common Stock-7.22B2.96B2.92B2.75B2.81B2.81B2.79B2.76B2.73B2.7B3.01B3B2.98B2.95B2.93B2.9B000002.77B2.65B2.4B2.11B1.89B1.51B1.09B1.06B00
Retained Earnings1.73B783M-286M-642M-280M1.21B1.17B5.43B4.64B4.97B6.42B5.52B4.77B4.04B4.09B3.33B2.65B5.95B5.02B11.54B9.76B8.87B7.89B6.47B5.16B4.15B3.33B2.54B2.01B701.9M492.8M
Treasury Stock0-6.37B-5.68B-4.91B-3.13B-2.19B-2.07B-1.79B-1.22B-731M-2.76B-2.25B-1.42B-1.08B-816M-457.7M-331M-343M-480.7M-8.22B-4.5B-3.04B-2.59B-1.14B-737M-457.2M-346.6M-17.2M-82.3M00
Accumulated OCI-161M-155M-167M-151M-114M-34M-104M-79M-92M-125M-116M-23M70M68M37M77M70M82.2M210.8M121M33.9M-3.1M22.6M-58.6M-131.3M-144.8M-94.3M-49M-33.3M00
Minority Interest160M147M1M1M3M3M3M2M020M17M00000000000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Negative equity and goodwill

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Persistent Negative Equity Position Persists

As reported in recent financial filings, Cardinal Health's equity position has remained consistently negative over the last ten quarters, bottoming at -$3.4 billion in 2026Q2 and currently sitting at -$2.8 billion, which suggests a structural imbalance between total assets and the company's mounting liabilities.

The persistent negative equity indicates that the company's historical accounting decisions and capital allocation strategies have eroded the book value of the firm. Investors should monitor whether this trend reflects aggressive share repurchases or the cumulative impact of impairment charges and litigation-related liabilities that continue to weigh on the balance sheet.

Goodwill Expansion Signals Acquisition Reliance

Based on the company's quarterly balance sheets, goodwill has expanded significantly from $4.0 billion in 2024Q2 to $13.7 billion by 2026Q3, representing a substantial portion of the $56.7 billion in total assets and highlighting a heavy reliance on inorganic growth to drive the business model.

This rapid accumulation of goodwill warrants further investigation into the underlying performance of acquired assets, as it increases the risk of future impairment charges if these units fail to meet return thresholds. The concentration of intangible assets relative to tangible infrastructure suggests that the firm's asset base is increasingly sensitive to valuation adjustments.

Tight Liquidity Buffers Remain Constant

According to the provided quarterly data, the current ratio has hovered narrowly between 0.91 and 1.02 over the past ten quarters, indicating that the company maintains a razor-thin liquidity buffer relative to its short-term obligations in the capital-intensive pharmaceutical distribution industry.

A current ratio consistently near or below 1.0 suggests that the firm relies heavily on the rapid turnover of its inventory and the timely collection of receivables to meet its immediate financial commitments. This lack of a significant liquidity cushion may leave the company vulnerable to sudden disruptions in the healthcare supply chain or unexpected shifts in working capital requirements.

Debt Load Rising Amid Expansion

As indicated by the latest financial statements, total debt has increased from $4.7 billion in 2024Q2 to $8.9 billion in 2026Q3, reflecting a strategic shift toward higher leverage to fund operations and acquisitions despite the company's already strained equity position.

The escalation in debt levels appears to be a necessity-driven response to support the firm's massive scale and ongoing transformation initiatives. Investors should monitor the interest coverage implications of this rising debt burden, especially given the low-margin nature of the distribution business which provides little room for error in servicing these obligations.

CAH — Frequently Asked Questions

Quick answers to the most common questions about buying CAH stock.

What are the total assets of Cardinal Health, Inc. (CAH)?

As of 2025, Cardinal Health, Inc. (CAH) had total assets of $53.12B including $36.37B in current assets.

How much debt does Cardinal Health, Inc. (CAH) have?

Cardinal Health, Inc. (CAH) carries total debt of $9.35B, offset by $3.87B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Cardinal Health, Inc.?

Cardinal Health, Inc. (CAH) has total shareholders' equity (book value) of $-2781.0M ($-10.88 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Cardinal Health, Inc.'s current ratio and liquidity?

Cardinal Health, Inc. (CAH) reported a current ratio of 0.94x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.